Page last updated: 2024-10-27

fluconazole and Experimental Hepatoma

fluconazole has been researched along with Experimental Hepatoma in 2 studies

Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tamura, K1
Inoue, K1
Takahashi, M1
Matsuo, S1
Irie, K1
Kodama, Y1
Gamo, T1
Ozawa, S1
Yoshida, M1
Korashy, HM1
Brocks, DR1
El-Kadi, AO1

Other Studies

2 other studies available for fluconazole and Experimental Hepatoma

ArticleYear
Involvement of constitutive androstane receptor in liver hypertrophy and liver tumor development induced by triazole fungicides.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2015, Volume: 78

    Topics: Alanine Transaminase; Animals; Aryl Hydrocarbon Hydroxylases; Cell Proliferation; Constitutive Andro

2015
Induction of the NAD(P)H:quinone oxidoreductase 1 by ketoconazole and itraconazole: a mechanism of cancer chemoprotection.
    Cancer letters, 2007, Dec-08, Volume: 258, Issue:1

    Topics: Animals; Antifungal Agents; Carcinoma, Hepatocellular; Enzyme Activation; Enzyme Induction; Fluconaz

2007